Topline Data from Phase 3 clinical trial of cefepime-taniborbactam in patients with complicated urinary tract infections (cUTIs) expected first quarter 2022 BARDA extends cost-sharing contract to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback